Akari Therapeutics PLC (AKTX)
0.9682
-0.01
(-1.20%)
USD |
NASDAQ |
Dec 27, 16:00
0.98
+0.01
(+1.22%)
After-Hours: 20:00
Akari Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| DBV Technologies SA | -0.109M |
| Ascendis Pharma AS | -- |
| Cellectis SA | 22.33M |
| Adaptimmune Therapeutics PLC | -66.02M |
| Biodexa Pharmaceuticals PLC | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.49M |
| Cash from Financing (Quarterly) | -0.443M |
| Free Cash Flow | -14.84M |
| Free Cash Flow Per Share (Quarterly) | -0.1222 |
| Free Cash Flow Yield | -187.2% |